Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003767873 | SCV000768461 | likely benign | Familial adenomatous polyposis 1 | 2024-05-18 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001191943 | SCV001359884 | likely benign | Hereditary cancer-predisposing syndrome | 2019-01-07 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001566972 | SCV001790571 | likely benign | not provided | 2019-12-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001191943 | SCV002650868 | likely benign | Hereditary cancer-predisposing syndrome | 2020-03-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Myriad Genetics, |
RCV003767873 | SCV005084469 | benign | Familial adenomatous polyposis 1 | 2024-04-02 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Ce |
RCV001566972 | SCV005892293 | likely benign | not provided | 2025-02-01 | criteria provided, single submitter | clinical testing | APC: BP4, BP7 |